Drager LF, Togeiro SM, Polotsky VY, et al
Wilding and his colleagues [Reference ONeil, Aroda, Astrup, Kushner, Lau and Wadden7] conducted a comprehensive analysis by combining data from various weight-management clinical trials [Reference Blackman, Foster, Zammit, Rosenberg, Aronne and Wadden22Reference Wadden, Hollander, Klein, Niswender, Woo and Hale27], focusing on the neuropsychiatric safety of liraglutide
semaglutide generally produces greater weight loss and glycemic effects, though cost and side effect profiles differ
See our 5-amino-1MQ dosing guide for proper protocols
Experimental design guidance for investigators Model selection and housing Use diet-induced obesity cohorts with pre-randomization by body weight and fat mass, defined sex and age, and thermoneutral housing to decouple thermogenic artifacts